Prenetics Global Limited (PRE) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PRE Revenue Growth
Revenue Breakdown
PRE's revenue distribution by segment and geography
By Geography
PRE Revenue Analysis (2019–2025)
As of May 8, 2026, Prenetics Global Limited (PRE) generated trailing twelve-month (TTM) revenue of $69.0 million, reflecting explosive growth of +202.8% year-over-year. The most recent quarter (Q3 2025) recorded $23.6 million in revenue, up 33.2% sequentially.
Looking at the longer-term picture, PRE's 5-year compound annual growth rate (CAGR) stands at +7.2%, indicating steady revenue expansion. The company achieved its highest annual revenue of $92.4 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including EXAS (+17.7% YoY), NTRA (+35.9% YoY), and CSTL (-2.1% YoY), PRE has outperformed the peer group in terms of revenue growth. Compare PRE vs EXAS →
PRE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $69M | +202.8% | +7.2% | -40.5% | ||
| $3.2B | +17.7% | +16.8% | -6.4% | ||
| $2.3B | +35.9% | +42.6% | -13.4% | ||
| $344M | -2.1% | +40.6% | -12.4% | ||
| $2.7B | -3.9% | +10.4% | -33.7% | ||
| $3.2B | +8.8% | +25.2% | 5.7% |
PRE Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $92.4M | +201.7% | $48.9M | 53.0% | $-37,383,999 | -40.5% |
| 2024 | $30.6M | +40.8% | $15.4M | 50.3% | $-48,144,000 | -157.2% |
| 2023 | $21.7M | +65.2% | $8.8M | 40.6% | $-51,906,718 | -238.7% |
| 2022 | $13.2M | +5.0% | $3.6M | 27.5% | $-66,022,000 | -501.5% |
| 2021 | $12.5M | -80.8% | $3.6M | 28.7% | $-56,661,847 | -452.1% |
| 2020 | $65.2M | +605.9% | $26.3M | 40.4% | $-995,126 | -1.5% |
| 2019 | $9.2M | - | $2.7M | 29.4% | $-20,803,285 | -225.3% |
See PRE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PRE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPRE — Frequently Asked Questions
Quick answers to the most common questions about buying PRE stock.
Is PRE's revenue growth accelerating or slowing?
PRE revenue is accelerating at +202.8% year-over-year, exceeding the 5-year CAGR of +7.2%. TTM revenue reached $69M. Growth momentum has increased versus prior periods.
What is PRE's long-term revenue growth rate?
Prenetics Global Limited's 5-year revenue CAGR of +7.2% reflects the sustained expansion pattern. Current YoY growth of +202.8% is above this long-term average.
How is PRE's revenue distributed by segment?
PRE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.